Iovance Biotherapeutics to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call and Webcast on Wednesday, ...
February 22 2019 - 7:00AM
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology
company developing novel cancer immunotherapies based on
tumor-infiltrating lymphocyte (TIL) technology, today announced
that it will report its fourth quarter and year-end 2018 financial
results on Wednesday, February 27, 2019. Management will host a
conference call and live audio webcast to discuss these results and
provide a corporate update at 4:30 p.m. EST.
To participate in the conference call, please dial
1-844-646-4465 (domestic) or 1-615-247-0257 (international) and
reference the access code 7055329. The live webcast can be accessed
under “News & Events” in the Investors section of the Company’s
website at www.iovance.com or at the
link: https://edge.media-server.com/m6/p/hijrs8as.
A replay of the call will be available from February 27,
2019 to March 7, 2019. To access the replay, please dial
1-855-859-2056 (domestic) or 1-404-537-3406 (international) and
reference the access code 7055329. The archived webcast will be
available for thirty days in the Investors section
at www.iovance.com.
About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is a clinical-stage
biotechnology company focused on the development of cancer
immunotherapy products for the treatment of various cancers. The
company's lead product candidate is an adoptive cell therapy using
TIL technology being investigated for the treatment of patients
with metastatic melanoma, recurrent and/or metastatic squamous cell
carcinoma of the head and neck, recurrent, metastatic or persistent
cervical cancer and locally advanced or metastatic non-small cell
lung cancer. For more information, please
visit http://www.iovance.com.
Investor Relations Contacts: Annie
ChangSolebury Trout646-378-2972achang@troutgroup.com
Chad RubinSolebury Trout646-378-2947crubin@troutgroup.com
Media Relations Contact: Rich AllanSolebury
Trout646-378-2958rallan@troutgroup.com
Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Apr 2023 to Apr 2024